Y-Intercept (HK)’s CareDx CDNA Stock Holding History

Y-Intercept (HK)’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$352K	Sell	12,353 -28,941	-70%	-$630K	0.01%	1422
2026 Q1	$717K	Buy	41,294 +15,246	+59%	+$289K	0.01%	1150
2025 Q4	$491K	Buy	+26,048	New	+$436K	0.01%	1242
2025 Q3	–	Sell	-19,474	Closed	-$381K	–	1607
2025 Q2	$381K	Buy	+19,474	New	+$346K	0.01%	1290
2024 Q3	–	Sell	-46,453	Closed	-$721K	–	1352
2024 Q2	$721K	Buy	+46,453	New	+$561K	0.04%	649
2024 Q1	–	Sell	-34,127	Closed	-$410K	–	1401
2023 Q4	$410K	Buy	34,127 +17,396	+104%	+$143K	0.04%	690
2023 Q3	$117K	Buy	+16,731	New	+$155K	0.01%	956
2021 Q4	–	Sell	-5,233	Closed	-$332K	–	605
2021 Q3	$332K	Buy	+5,233	New	+$398K	0.06%	439
2021 Q2	–	Sell	-8,734	Closed	-$550K	–	649
2021 Q1	$550K	Buy	+8,734	New	+$678K	0.15%	230

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Y-Intercept (HK)'s CDNA Position: Q2 2026 in Review

Y-Intercept (HK) reduced its CareDx (CDNA) stake by 70% in Q2 2026, selling an estimated $630K and leaving 12,353 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #1422.

Y-Intercept (HK) first reported a position in CDNA in Q1 2021 and has held it in 9 quarters since. The position peaked at $721K in Q2 2024. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Y-Intercept (HK) held 12,353 shares of CareDx worth $352K as of Q2 2026.
Y-Intercept (HK) sold 28,941 CareDx shares in Q2 2026, an estimated $630K.
CareDx made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1422 holding.
Y-Intercept (HK) first reported a position in CareDx in Q1 2021 and has held it in 9 quarters since.
Y-Intercept (HK)'s CareDx position peaked at $721K in Q2 2024.
228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.